Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intradermal immunization of mice with cholera toxin B-pneumococcal surface protein A fusion protein is protective against intraperitoneal challenge with Streptococcus pneumoniae.

× No keyword cloud information.

19 in total

1. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Authors: A H Tu; R L Fulgham; M A McCrory; D E Briles; A J Szalai
Journal: Infect Immun Date: 1999-09 Impact factor: 3.441

2. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors: D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal: Infect Immun Date: 2000-02 Impact factor: 3.441

3. Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity.

Authors: Dexiang Chen; Ryan L Endres; Cherie A Erickson; Yuh-Fun Maa; Lendon G Payne
Journal: Vaccine Date: 2002-06-21 Impact factor: 3.641

4. Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.

Authors: Eliane N Miyaji; Daniela M Ferreira; Alexandre P Y Lopes; M Cristina C Brandileone; Waldely O Dias; Luciana C C Leite
Journal: Infect Immun Date: 2002-09 Impact factor: 3.441

5. Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2.

Authors: Marco Rusnati; Chiara Urbinati; Elena Tanghetti; Patrizia Dell'Era; Hugues Lortat-Jacob; Marco Presta
Journal: Proc Natl Acad Sci U S A Date: 2002-03-26 Impact factor: 11.205

6. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.

Authors: E N Miyaji; W O Dias; M Gamberini; V C Gebara; R P Schenkman; J Wild; P Riedl; J Reimann; R Schirmbeck; L C Leite
Journal: Vaccine Date: 2001-12-12 Impact factor: 3.641

7. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.

Authors: D E Briles; S K Hollingshead; J King; A Swift; P A Braun; M K Park; L M Ferguson; M H Nahm; G S Nabors
Journal: J Infect Dis Date: 2000-11-08 Impact factor: 5.226

8. A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection.

Authors: Michael Lebens; Jia-Bin Sun; Hamid Sadeghi; Malin Bäckström; Ida Olsson; Nathalie Mielcarek; Bin-Ling Li; Andre Capron; Cecil Czerkinsky; Jan Holmgren
Journal: Vaccine Date: 2003-01-17 Impact factor: 3.641

9. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.

Authors: Fabienne Anjuère; Annie George-Chandy; Florence Audant; Déborah Rousseau; Jan Holmgren; Cecil Czerkinsky
Journal: J Immunol Date: 2003-02-01 Impact factor: 5.422

10. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli.

Authors: Ana Paula de Mattos Arêas; Maria Leonor Sarno de Oliveira; Celso Raul Romero Ramos; Maria Elisabete Sbrogio-Almeida; Isaías Raw; Paulo Lee Ho
Journal: Protein Expr Purif Date: 2002-08 Impact factor: 1.650